Oral Pyridoxal 5'-Phosphate for the Treatment of Patients With PNPO Deficiency
Trial details
- Registry ID
- NCT04706013
- Drugs studied
- Pyridoxal Phosphate
TrialRedline tracks 1 clinical trial sponsored by Medicure: 1 Phase 3.
Company identity has not yet been verified
| Trial | Drugs studied | Status | Primary completion |
|---|---|---|---|
| Oral Pyridoxal 5'-Phosphate for the Treatment of Patients With PNPO DeficiencyNCT04706013 | Pyridoxal Phosphate | Active not recruiting | 2027-09Estimated |
Names as written in the registry records.
NCT04706013 · Medicure
Before: Nov 2026. After: Sep 2027.
Before: Recruiting. After: Active not recruiting.